skip to primary navigationskip to content

Dr Wendi Anne Bacon

My goal is to develop single-cell sequencing technologies to create a cellular atlas of the developing placenta in mouse and human, with the particular aim of determining what goes wrong in cases of pregnancy complications.
Dr Wendi Anne  Bacon

Postdoctoral Research Associate

Office Phone: +44 (0) 1223 336874

Research Interests

I am interested in the development of novel single cell sequencing techniques aimed at analysing the placenta as our model system. By better characterizing tissues – placenta or otherwise – at a single cell level, we can move beyond understanding cell populations as an average (i.e. Britons drink tea) and instead as individual and often unique cells contributing to an overall system (i.e. some Britons drink more tea than others; some like coffee instead; some like both tea and coffee, and some like neither. Fascinating, eh?). Single cell analysis will allow us to discover new cell types among seemingly ‘homogeneous’ samples and tissues, in order to better understand the complex interplay between cells as well as identify subtle changes in those cell types that may be involved in disease pathologies such as pre-eclampsia.


Professor Chris Abell

Dr Myriam Hemberger

Professor Graham Burton

Dr Francesco Colucci

Dr Miguel Constancia

Key Publications

Sivaraj D, Bacon W, Long GD, Rizzieri DA, Horwitz ME, Sullivan KM, Kang Y, Li Z, Chao NJ, Gasparetto C. High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma. Bone Marrow Transplant. 2018 Jan

Huang LW, Bacon W, Cirrincione C, Peterson B, Long G, Rizzieri D, Sullivan KM, Corbet K, Horwitz M, Chao N, Gasparetto C, Tuchman SA. Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma. Hematol Oncol. 2017 Dec

Barrett NA, Malouf C, Kapeni C, Bacon WA, Giotopoulos G, Jacobsen SEW, Huntly BJ, Ottersbach K. Mll-AF4 confers enhanced self-renewal and lymphoid potential during a restricted window in development. Cell Reports. 2016 Jul 26

Mascarenhas MI, Bacon WA, Kapeni C, Fitch SR, Kimber G, Cheng SW, Li J, Green AR, Ottersbach K. Analysis of cytokine signalling reveals resistance of embryonic hematopoietic stem cells to myeloproliferative disease mutation. Blood. 2016 Feb 10.

Tuchman SA, Bacon WA, Huang LW, Long G, Rizzierie D, Horwitz M, Chute JP, Sullivan K, Morris Engemann A, Yopp A, Li Z, Corbet K, Chao N, Gasparetto C. Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma. J Clin Apher. 2014 Oct 8.

Olson IA, Bacon WA, Baez Sosa YY, Delaney KM, Forte SA, Guglielmo MA, Hill AN, Kiesow KH, Langenbacher RE, Xun Y, Young RO, Bowyer WJ. Measurement of heterogeneous reaction rates: three strategies for controlling mass transport and their application to indium-mediated allylations. J Phys Chem A. 2011 Oct 13